ImmuCell announces 46% increase in third-quarter product sales
ICCC•ImmuCell reported preliminary, unaudited third-quarter 2026 sales of $8 million, up 46% from the same quarter in 2025. The company will discontinue early sales reporting and report revenue at quarterly events.
1. Preliminary sales results
ImmuCell reported preliminary, unaudited third-quarter 2026 total sales of $8 million, up 46% from the third quarter of 2025. The company said it will discontinue early sales reporting and report revenue at quarterly events.
